The Venture Codex Logo

The Venture Codex

Rayvio

3980 Trust Way, Hayward, CA, 94545, United States

Overview

RayVio Corp. is an advanced health and hygiene company based in Hayward, Calif., that develops powerful UV LED technology to disinfect water, surfaces and air. Its core products include point-of-use water disinfection and OEM-integrated solutions that create new markets and revenue streams. The company emphasizes compact, portable UV LED modules that enable on-demand disinfection without chemicals or costly consumables. RayVio positions its technology as an alternative to mercury-based or inefficient ultraviolet solutions. With rising global demand for safe water and cleaner environments, the company plans to scale production and expand manufacturing front-end and back-end capacity. RayVio also intends to double its workforce and grow global sales, marketing, application support, distribution channels and continue research and development. RayVio develops patent-protected UV LED technology and materials originally developed at Boston University by co-founders Dr. Yitao Liao and Prof. Theodore Moustakas. Its solutions claim up to a 10x performance increase over existing UV products, enabling higher performance at lower cost and power. The company targets industrial, commercial and consumer sectors with applications ranging from hand-held disinfection devices and point-of-use water faucets to industrial curing and UV medical treatment devices. RayVio says its technology can enable water, surface and air disinfection as well as medical treatments for conditions mentioned in the company materials. The company emerged from stealth and plans a series of product announcements later this year. RayVio intends to use new capital to accelerate its go-to-market strategy, grow its team, and enable mass adoption of UV LED solutions.

Total raised
$35M
Funding rounds
2
Latest round
Equity
Latest activity
Apr 2016

Industries

  • Electronics
  • Industrial
  • Water Purification
Visit website

Recent funding

  1. Equity

    Apr 2016

    $26M

  2. Series B

    Mar 2015

    $9M

Team

No current team members are available.